Storia in 1 fonti

The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says

Fujifilm Biotechnologies CEO Lars Petersen says CDMOs must expand modalities, embrace AI, and boost biosimilar capacity amid biopharma's $300B patent cliff.

Raccontata da

endpoints.news

Timeline cronologica

lunedì 27 luglio 2026·endpoints.news
The patent cliff is looming and CDMOs need to be prepared, Fujifilm CEO says
Fujifilm Biotechnologies CEO Lars Petersen says CDMOs must expand modalities, embrace AI, and boost biosimilar capacity amid biopharma's $300B patent cliff.